Pharmaceutical Counterfeits Threaten $1 Billion Pipeline of Product The Issue Counterfeit copies of a major pharmaceutical brand were discovered in the US market. With no security measures in place to allow patients or inspectors to readily distinguish authentic from counterfeit goods, both patient welfare and the manufacturer’s reputation were under threat. Given such risks, the $1 billion of authentic product, which was in the distribution pipeline, could not be sold without some means of allowing patients and retailers to verify that the product was authentic. The Solution The product was repackaged to include a variety of authentication features that could be identified by patients and inspectors, both in the field and in the laboratory. These included: Overt color-shifting ink that co

Join for free to read